Veeva Systems Inc. · NYSE:VEEV
Veeva Systems — J.P. Morgan Healthcare Conference 2016
23 slides from Veeva Systems's conference presentation, Jan 14, 2016
Slide 1: J.P. Morgan Healthcare Conference Investor Presentation
J.P. Morgan Healthcare Conference Investor Presentation Matt Wallach, President & Co-Founder January 14, 2016 ®2016 Veeva Systems veeva.com |
Slide 2: Safe Harbor
Safe Harbor Forward-looking Statements This presentation contains forward-looking statements, including statements regarding Veeva's future financial outlook and financial performance, market growth, the release dates for and benefits from the use of Veeva's solutions, our partnership plans, our str
Slide 3: A Leading Provider of Cloud Solutions to the Global Life Sciences Industry
A Leading Provider of Cloud Solutions to the Global Life Sciences Industry Founded in 2007 $400M+ FY16 Revenue 1400+ Employees HQ in Pleasanton, CA ®2016 Veeva Systems veeva.com | 3
Slide 4: Vision and Values
Vision Become the Leading Cloud Solutions Provider to the Global Life Sciences Industry Values Customer Success Employee Success Speed ®2016 Veeva Systems veeva.com | 4
Slide 5: Investor Highlights
Investor Highlights Revenue and Profitability $313m $295m Industry Cloud Business Model $226m $210m Large Market Opportunity Broad, Growing Suite of Products $130m Blue Chip Customer Base $86m $83m $61m Unique Combination of High $47m $30m Growth and Strong Profitability FY’13 FY’14 FY’15 YTD’15¹ YT
Slide 6: Emergence of Industry Cloud
Emergence of Industry Cloud Industry Cloud Horizontal Industry Cloud Horizontal Client/Server Client/Server 2010+ 2000s 1990s ®2016 Veeva Systems veeva.com | 6
Slide 7: Largest Segment of the Software Market
Largest Segment of the Software Market Total Worldwide Software Market Share, 2014 Vertical Specific Software 9% Operating Systems 3% 4% Database Management Systems Other Application Software 4% 27% ERP 4% $115B App Infrastructure / Middleware CRM 4% IT Operations 5% Security 8% Office Suites 5% Sto
Slide 8: ...and with the Most Growth
Change in spending from 2013 ($B) Thousands -2 -1 0 1 2 3 4 5 6 7 8 Vertical Specific ®2016 Veeva Systems Other applications CRM Middleware DMS ERP IT Ops Security Source: Gartner, Market Share: All Software Markets Worldwide 2014, March 2015 Supply Chain Mgmt Storage Mgmt BI & Analytics Social …and
Slide 9: The Old Software Adage
The Old Software Adage The best software doesn’t always win. ®2016 Veeva Systems veeva.com | 9
Slide 10: The New Reality
The New Reality The best cloud software will always win. ®2016 Veeva Systems veeva.com | 10
Slide 11: Significant IT Spend and Large Market Opportunity
Significant IT Spend and Large Market Opportunity $52B Annual Life Sciences IT Spending $5B+ Current Addressable Market $19B $2B Sales Productivity & Compliance Tools (CRM) Infrastructure $1B Master Data Management & Data (Network & OpenData) $33B Software & Services $2B+ Content Management (Vault)
Slide 12: 2015 New Drug Approvals Hit 66-year High
2015 New Drug Approvals Hit 66-year High 44 51 Product approvals Product approvals 2014 2015 Sources: Forbes: 2014 New Drug Approvals Hit 18-Year High. Jan 2, 2015 Forbes: 2015 New Drug Approvals Hit 66-Year High. Jan 4, 2016 ®2016 Veeva Systems veeva.com | 12
Slide 13: Veeva Spans an Entire Life Sciences Company
Veeva Spans an Entire Life Sciences Company Research & Development Medical Commercial Clinical Quality and Medical Field Regulatory Marketing Sales Trials Manufacturing Affairs Medical Approved Events Align CRM CLM Engage CoBrowse Email Management Regulatory Investigator Information eTMF QualityDocs
Slide 14: Integrated + Best-of-Breed
INTEGRATED + BEST-OF-BREED ®2016 Veeva Systems veeva.com |
Slide 15: Veeva Commercial Cloud
Veeva Commercial Cloud DATA INTERACTIONS CONTENT ®2016 Veeva Systems veeva.com | 15
Slide 16: R&D Cloud
R&D Cloud CLINICAL QUALITY REGULATORY PLATFORM ®2016 Veeva Systems veeva.com | 16
Slide 17: Select Veeva Customers
Select Veeva Customers 375+ customers with users in over 80 countries Enterprise Emerging Growth ®2016 Veeva Systems veeva.com | 17
Slide 18: Targeting a $1B Revenue Run-rate in CY2020
Targeting a $1B Revenue Run-rate in CY2020 $1B ~50% ~$400M+ 75% ~35-40% 20% ~10-15% 2015 2020 (FY16 Guidance) (CY Revenue Run Rate) CRM Vault Network / OpenData / Other ®2016 Veeva Systems veeva.com | 18
Slide 19: Vault Tracking Ahead vs. Early Days of CRM
Vault Tracking Ahead vs. Early Days of CRM Total revenue through first ~4 years of sales by product line Vault CRM Quarters after product line launch Note: First quarter of sales was Q2’08 for CRM and Q2’12 for Vault ®2016 Veeva Systems veeva.com | 19
Slide 20: Vault Customers Expand Over Time
Vault Customers Expand Over Time Annualized Vault subscription revenue by annual cohort Avg. Vaults per customer 1.3 1.2x 3.0x 2.0 9.6x 2.2 First year Q2'16 ®2016 Veeva Systems 2013 2014 2015 veeva.com | 20
Slide 21: Competitive Advantage
Competitive Advantage Amazing Industry Deep Industry- Regulatory Cloud Expertise Specific Compliance in Software Functionality the Cloud ®2016 Veeva Systems veeva.com | 21
Slide 22: Most Important Competitive Advantage
Most Important Competitive Advantage ®2016 Veeva Systems veeva.com | 22
Slide 23: Thank You
Thank You ®2016 Veeva Systems veeva.com |
Veeva Systems — J.P. Morgan Healthcare Conference 2016 on 6ix